BridgeBio Pharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
BridgeBio Pharma, Inc.
CIK #0001743881, 0002076615
EDGAR Form CIK 2011 - 2026
10-K [0001743881]
10-Q [0001743881]
3 [0001743881]
4 [0001743881]
5 [0001743881]
8-K [0001743881]
SC 13D [0001743881]
SC 13G [0001743881]
3 [0002076615]
4 [0002076615]
SC 13D [0002076615]
Form 13D/13G Filer Form 13D/13G Subject Filed
Farallon Capital Partners LP Bridgebio Pharma Inc [2026-05-29]
Janus Henderson Group PLC Bridgebio Pharma Inc [2026-02-17]
Price T Rowe Associates Inc /MD/ Bridgebio Pharma Inc [2025-11-14]
Bridgebio Pharma LLC Bridgebio Oncology Therapeutics Inc [2025-08-18]
State Street Corp Bridgebio Pharma Inc [2023-02-08]
Vanguard Group Inc Bridgebio Pharma Inc [2021-02-10]
BlackRock Inc Bridgebio Pharma Inc [2021-02-05]
Eidos Therapeutics Inc Bridgebio Pharma Inc [2020-10-15]
Kumar Neil Bridgebio Pharma Inc [2020-02-14]
American International Group Inc Bridgebio Pharma Inc [2020-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
BridgeBio Pharma, Inc.
Satvat Ali J.
Cook Jennifer E.
Valantine Hannah
Lo Andrew
Homcy Charles J
Aguiar Eric
Daniels Ronald J
Ellis Andrea
Hassan Fred
View All
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com